Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Federal Reserve shifts to quarter-point rate rise but warns of more to come
    • ‘Hybrid identities’: why Germany is updating its citizenship rules
    • ECB set to raise rates despite fall in eurozone inflation
    • Brussels urged to rein in Ukraine’s ‘unrealistic’ EU hopes
    • Italy to join forces with France in supplying air defences to Ukraine
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Adani sell-off tops $90bn as share sale fails to ease crisis
      • ‘Extreme leverage’? Adani’s debt-driven expansion under scrutiny
      • Adani Enterprises calls off $2.4bn share sale
      • Perella Weinberg banker tied to insider trading probe found dead
      • How First Abu Dhabi Bank pursued Standard Chartered and ‘opened Pandora’s box’
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news: FedEx to cut global leadership team by more than 10%
      • Adani Enterprises calls off $2.4bn share sale
      • Perella Weinberg banker tied to insider trading probe found dead
      • US stocks jump after Fed announces smaller rate rise
      • Lebanon devalues official exchange rate by 90%
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • End the Fed ‘put’
      • When good economic news may not be good news
      • The return of the ‘British disease’
      • Conservatives are too keen on money to win the culture war
      • Conservatives are forced to face the economic case for net zero
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
      • A new generation refuses to keep quiet on age discrimination at work
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The secrets of the Mercedes-Benz Holy Halls
      • Alexa Chung on the unpolished appeal of Indie Sleaze
      • Why I’m only buying five new things in 2023
      • Whitechapel Gallery offers thrilling landmark show of female abstract artists — review
      • Episode 3 of ‘The Last of Us’ shows TV at its best
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Alex Azar

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 6 January, 2021
      Coronavirus treatment
      US states urged to be more flexible distributing Covid-19 jabs

      Health secretary calls for wider access to vaccines to ensure they do not go unused

    • Thursday, 17 September, 2020
      US presidential election 2020
      Trump team vs the scientists: the battle over Covid ahead of election

      Political operatives and public health officials spar over how to portray severity of pandemic

    • Sunday, 28 June, 2020
      Donald Trump
      Trump deletes retweet of supporter yelling ‘white power’

      President criticised for praising a rally that included a racist chant

    • Wednesday, 4 March, 2020
      US politics & policy
      House of Representatives approves $8bn coronavirus response bill

      Bipartisan agreement on measures to fund response comes as US virus cases and deaths rise

    • Monday, 2 March, 2020
      Coronavirus pandemic
      Pence backs US school closures in fight against coronavirus

      Trump administration steps up response after expanding travel restrictions

    • Saturday, 29 February, 2020
      Coronavirus pandemic
      Public health experts call coronavirus a ‘pandemic’ 

      Doctor treating US cases says hospitals should prepare for surge of patients

    • Tuesday, 25 February, 2020
      Coronavirus pandemic
      Wall Street falls sharply for second day on coronavirus fears

      S&P 500 dips 3% and Treasury yields touch record low as Asian stocks join falls

    • Tuesday, 25 February, 2020
      Coronavirus pandemic
      US health official warns public to prepare for coronavirus outbreak

      People told to brace for potentially ‘severe’ disruptions as Democrats question readiness

    • Thursday, 6 February, 2020
      Gillian Tett
      Coronavirus shows risk of Trump cuts to health spending

      Private sector may not be able to pick up the slack on drug and vaccine development

    • Saturday, 1 February, 2020
      Coronavirus pandemic
      Australia joins US in barring foreigners who recently visited China

      Restrictions come as coronavirus death toll rises

    • Thursday, 2 January, 2020
      Tobacco
      US health officials unveil e-cigarette restrictions

      Critics complain policy targeting some flavoured cartridges does not go far enough

    • Thursday, 19 December, 2019
      FirstFT
      FirstFT: Today’s top stories

      Your daily briefing on the news

    • Wednesday, 18 December, 2019
      Drug prices
      White House lays out plan to import cheaper drugs from Canada

      Trump plan focuses on campaign issue while decrying impeachment

    • Friday, 13 December, 2019
      FT Swamp Notes
      The saga of Ivanka’s stolen jewellery

      What stolen jewellery says about healthcare under Trump 

    • Thursday, 7 November, 2019
      Gilead Sciences Inc
      US sues Gilead over HIV patent infringements

      Lawsuit claims drugmaker reaped billions of dollars through taxpayer-funded research

    • Friday, 13 September, 2019
      News in-depthTobacco
      Vaping fears cast cloud over US tobacco industry

      Companies brace for possible crackdown as concerns grow over spike in lung disease

    • Wednesday, 11 September, 2019
      Health sector
      Trump considers ban on flavoured e-cigarettes

      Health officials have increased scrutiny of vaping after lung illnesses and deaths

    • Friday, 30 August, 2019
      Juul Labs
      Juul Labs increases debt offering amid FDA review

      Ecigarette group raises almost $800m despite increasing regulatory scrutiny of vaping

    • Wednesday, 31 July, 2019
      Drug prices
      Trump unveils plan to legalise medicine imports from Canada

      Move comes as drug prices become a focus of 2020 presidential campaign

    • Tuesday, 23 July, 2019
      ExplainerDrug prices
      For all his tough talk, can Donald Trump lower drug prices?

      President’s efforts to reduce high cost of pharmaceuticals for patients have so far failed

    • Thursday, 11 July, 2019
      Drug prices
      Trump drops plan to squeeze drug industry middlemen

      Shares in Cigna, United Health and CVS rise after White House announcement

    • Friday, 14 June, 2019
      Drug prices
      Drugmakers sue to stop rule requiring prices in TV ads

      Amgen, Merck and Eli Lilly say Trump administration’s move infringes on free speech

    • Thursday, 16 May, 2019
      The FT ViewThe editorial board
      US drug pricing is in need of an overhaul

      The structure of the market suits everyone involved, except for ill Americans

    • Wednesday, 8 May, 2019
      Drug prices
      Drugmakers told to disclose prices in US TV ads

      Trump administration attempts to pressure pharmaceutical companies into lowering prices

    • Friday, 12 April, 2019
      Health
      FT Health: The struggle for women’s rights

      World population report, Unicef’s Henrietta Fore, astronaut twins

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In